arrow
M

Minetta C. Liu

Natera, Inc.
H指数:60
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial

ctDNA阳性的结直肠癌患者术后辅助化疗: 一项随机3期试验

2026-06-080
OAAI
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma

肿瘤信息指导的循环肿瘤DNA对肛管鳞状细胞癌的复发风险和生存期进行分层。

2026-02-260
OAAI
Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy

循环肿瘤DNA在评估接受新辅助治疗的局部晚期直肠癌患者肿瘤反应中的价值

Cancers
IF4.4
2026-02-110
OAAI
Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancers

Mehta, R.; Rivero-Hinojosa, S.; Dayyani, F.; Ferguson, J.; Shariff, B.; Aushev, V.N.; Budde, G.L.; Ortiz, J.B.; George, G.V.; Sharma, S.; et al. 循环肿瘤DNA为复发性/转移性胃肠癌患者的临床实践提供信息。Cancer 2026, 132, e70242. [Google Scholar] [CrossRef]

Cancer
IF5.1
2026-01-012
PRE
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors

循环肿瘤DNA细化新辅助治疗耐药乳腺肿瘤的危险分层

2025-12-090
OAAI
Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?

卵巢癌患者接受PARPi维持治疗时的循环肿瘤DNA监测:我们能否进一步个性化治疗?

2025-11-170
PRE
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study

分子残留病灶及复发在行术前手术的直肠癌患者中的研究:一项前瞻性队列研究

2025-09-260
OAAI
ASO Visual Abstract: Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors–a Feasibility Study

ASO视觉摘要:在转移性恶性叶状肿瘤患者中可靠检测到循环肿瘤DNA(ctDNA)——一项可行性研究

2025-08-180
PRE
Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker study

局部晚期可切除胃或胃食管结合部腺癌治疗期间纵向循环肿瘤DNA分析:PLAGAST前瞻性生物标志物研究

2025-07-240
OAAI
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study

循环肿瘤DNA (ctDNA) 可靠地检测到于转移性恶性叶状肿瘤患者中

2025-07-230
PRE
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
2025-03-010
OA
Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial
2025-02-010
OAAI
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)
2025-01-070
OA
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer
2024-11-010
OAAI
CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108

单药他莫昔芬治疗的转移性乳腺癌患者的CYP2D6活性: ECOG-ACRIN E3108的结果

2024-10-210
PRE
ctDNA-based molecular residual disease and survival in resectable colorectal cancer

可切除结直肠癌中基于ctDNA的分子残留疾病和生存

2024-09-161
OAAI